Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir 1998; 12: 1209-18

Bel EH, Sousa A, Fleming L et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative. Thorax 2010 doi: 10.1136/thx.2010.153643

British Thoracic Society and Scottish Intercollegiate Guideline Network. British guideline on the management of asthma. Thorax 2008; 63 (suppl 4):iv1-121

BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease. BTS Standards of Care Committee. Thorax 2008; 63 (Suppl 1): i1-i16

Brito de Sá A. Severe asthma: summary of review and some discussion areas. Review carried out for IPRCG. January 2012.

Cakmak S, Dales RE, Coates F. Does air pollution increase the effect of aeroallergens on hospitalization for asthma? J Allergy Clin Immunol 2012; 129: 228-31

Currie GP, Douglas JG, Heaney LG. Difficult to treat asthma in adults. BMJ 2009; 338: 593-597

Currie GP, Jackson CM, Lee DK, Lipworth BJ. Allergen sensitization and bronchial hyper-responsiveness to adenosine monophosphate in asthmatic patients. Clin Exp Allergy 2003; 33: 1405-1408

Emilsson M, Berndtsson I, Lötvall J,  et al. The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J 2011; 20:141-147. DOI:

Fonseca JA, Nogueira-Silva L, Morais-Almeida M, Azevedo L, Sa-Sousa A, Branco-Ferreira M, Fernandes L, Bousquet J. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010 Aug;65(8):1042-8. Epub 2010 Feb 1.

Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ 2005; 330: 644-8

Global Strategy for Asthma Management and Prevention. GINA 2011

Available at:

Haughney J, Price D, Kaplan A, et al. Achieving asthma control in practice: Understanding the reasons for poor control. Respiratory Medicine 2008; 102: 1681-1693

Heaney LG, Conway E, Kelly C et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003; 58: 561-516

Heaney, LG and Horne, R. Non-adherence in difficult asthma: Time to take it seriously. Thorax 2012; 67: 268-70

Horne, R. Adherence to asthma medication: A question of ability? Prim Care Respir J 201120: 118-9. 

Horne R, Musgrave S, Lee A, Price D. The Minimal Asthma Assessment Tool (MAAT): a new method for prioritising patients for primary care review by identifying poor asthma control and the causes of poor control. Gen Pract Airways Group Ann Conf 2005; AB07: 16 [Abstract]

Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005; 60: 309-316

Hylkema MN, Sterk PJ, de Boer WI, Postma DS. Tobacco use in relation to COPD and asthma. Eur Respir J 2007; 29 (3): 438-445

International Primary Care Respiratory Group. Tackling the smoking epidemic: IPCRG International guidance on smoking cessation in primary care. (accessed February 2012)

Juniper EE, Bousquet J, Abetz L, Bateman ED. Identifying ‘well-controlled’ and ‘not well-controlled asthma using the Asthma Control Questionnaire. Respir Med 2006; 100: 616-21

Kerstjens HA, Overbeek SE, Schouten JP, Brand PL, Postma DS. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group. Eur Respir J 1993; 6 (6): 868-76

Kiotseridis H, Bjermer L, Pilman E et al. ALMA, a new tool for the management of asthma patients in clinical practice: development, validation and initial clinical findings. Prim Care Respir J 2012

Launbach RJ, Kipen HM. Respiratory health effects of air pollution: update on biomass smoke and traffic pollution. J Allergy Clin Immunol 2012; 129:3-11

Loerbroks A, Apfelbacher CJ, Thayer JF, Debling D, Sturmer T. Neuroticism, extraversion, stressful life events and asthma: a cohort study of middle-aged adults. Allergy 2009; 64 (10): 1444-50

Malmstrom K, Rodriguez-Gomez G, Guerra J et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130 (6): 487-95.

National Prescribing Centre UK. Rapid Reviews – for example, Inhaled corticosteroids and the risk of diabetes

National Prescribing Centre UK. Rapid Reviews. High-dose inhaled corticosteroids in asthma. (2nd edition)

Nogueira-Silva L, Martins SV, Cruz-Correia R, Azevedo LF, Morais-Almeida M, Bugalho-Almeida A, Vaz M, Costa-Pereira A, Fonseca JA. Control of allergic rhinitis and asthma test--a formal approach to the development of a measuring tool. Respir Res. 2009 Jun 17;10:52.

Pinnock H, Adlem L, Gaskin S, Harris J, Snellgrove C, Sheik Al. Accessibility, clinical effectiveness and practice costs of providing a telephone option for routine asthma reviews: controlled implementation study. Br J Gen Pract 2007; 57: 714-22

Price D, Bond C, Bouchard J et al. International Primary Care Respiratory Group (IPRCG) Guidelines: management of allergic rhinitis. Prim Care Respir J 2006; 15 (1): 58-70

Price D, Crockett A, Arne M et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Primary Care Respiratory Journal 2009; 18 (3): 216-223

Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006; 61 (6): 737-742

Robinson DS, Campbell DA, Durham SP, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22: 478-483

Roberts NJ, Mohamed Z, Wong PS, Johnson M, Loh LC, Partridge MR. The development and comprehensibility of a pictorial asthma action plan. Patient Educ Couns 2009; 74(1):12-18.

Roberts N, Evans G, Blenkhorn P, Partridge M. Development of an electronic pictorial asthma action plan and its use in primary care. Patient Educ Couns 2010; 80(1):141-146.

Ryan D, van Weel C, Bousquet J et al. Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy 2008; 63: 981-9

Sedlack V, Chlumsky J, Terl M et al. Guidelines for diagnostics and therapy of difficult-to-control asthma.

Sin DD, Sutherland ER. Obesity and the lung: 4. Obesity and asthma. Thorax 2008; 63: 1018-1023

Siroux V, Oryszczyn MP, Varraso R et al. Environmental factors for asthma severity and allergy: results from the EGEA study (article in French, translated to English) Rev Mal Respir 2007; 24: 599-608

Spector S. Noncompliance with asthma therapy – are there solutions? J Asthma 2000; 37 (5): 381-388

Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. NEJM 2000; 343: 332-336

The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC Lancet 1998; 351 (9111): 1225-1232

Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med 2006; 6 (Suppl 1): S4

Thomas M, Gruffydd-Jones K, Stonham C, Ward S, Macfarlane T. Assessing asthma control in routine clinical practice: use of the Royal College of Physicians ‘3 Questions.’ Prim Care Resp J 2009; 18: 83-88

To T, Stanojevic S, Moores G et al. Global asthma prevalence in adults: findings from cross-sectional world health survey. BMC Public Health 2012; 12: 204

Toren K, Blanc P. Asthma caused by occupational exposures is common: a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med 2009; 9: 7

Tuomisto L, Erhola M, Kaila M et al. Asthma programme in Finland: High consensus between general practitioners and pulmonologists on the contents of an asthma referral letter. Primary Care Respiratory Journal 2004; 13: 205-210

Woodcock A, Forster L, Matthews E, et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. NEJM 2003; 349: 225-236

World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003

  • No labels